Exact Mass: 581.3650936

Exact Mass Matches: 581.3650936

Found 39 metabolites which its exact mass value is equals to given mass value 581.3650936, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

5-O-beta-D-mycaminosyl-20-oxotylonolide

20-Oxo-5-O-beta-mycaminosyltylactone; 23-Deoxy-5-O-beta-mycaminosyltylonolide

C31H51NO9 (581.3563636)

A macrolide antibiotic that is 20-oxotylactone having a 5-O-beta-D-mycaminosyl residue attached at position 6.

Rosamicin

2-(9-{[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-3-ethyl-7-hydroxy-2,8,12,16-tetramethyl-5,13-dioxo-4,17-dioxabicyclo[14.1.0]heptadec-14-en-10-yl)acetaldehyde

C31H51NO9 (581.3563636)

Rosamicin

2-[(1S,2R,3R,7R,8S,9S,10R,12R,14E,16S)-9-[(2S,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-7-hydroxy-2,8,12,16-tetramethyl-5,13-dioxo-4,17-dioxabicyclo[14.1.0]heptadec-14-en-10-yl]acetaldehyde

C31H51NO9 (581.3563636)

A macrolide antibiotic with activity against Neisseria gonorrhoeae, Chlamydia trachomatis, Ureaplasma urealyticum and Mycoplasma hominis. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007933 - Leucomycins C784 - Protein Synthesis Inhibitor > C261 - Macrolide Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic Origin: Microbe

PS(22:0/0:0)

1-docosanoyl-glycero-3-phosphoserine

C28H56NO9P (581.3692496)

LPS 22:0

1-docosanoyl-glycero-3-phosphoserine

C28H56NO9P (581.3692496)

2-[(2R,3R,7R,8S,9S,10R,12R,14E)-9-[(2R,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-7-hydroxy-2,8,12,16-tetramethyl-5,13-dioxo-4,17-dioxabicyclo[14.1.0]heptadec-14-en-10-yl]acetaldehyde

2-[(2R,3R,7R,8S,9S,10R,12R,14E)-9-[(2R,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-7-hydroxy-2,8,12,16-tetramethyl-5,13-dioxo-4,17-dioxabicyclo[14.1.0]heptadec-14-en-10-yl]acetaldehyde

C31H51NO9 (581.3563636)

1-Hexadecyl-2-succinyl-sn-glycero-3-phosphocholine

C28H56NO9P (581.3692496)

(4E,8E,12E)-3-hydroxy-2-[[(4Z,7Z)-2-hydroxyhexadeca-4,7-dienoyl]amino]hexadeca-4,8,12-triene-1-sulfonic acid

C32H55NO6S (581.374989)

(4E,8E,12E)-3-hydroxy-2-[[(10Z,12Z)-2-hydroxyoctadeca-10,12-dienoyl]amino]tetradeca-4,8,12-triene-1-sulfonic acid

C32H55NO6S (581.374989)

2-Amino-3-[hydroxy-(2-undecanoyloxy-3-undecoxypropoxy)phosphoryl]oxypropanoic acid

C28H56NO9P (581.3692496)

2-Amino-3-[(2-decanoyloxy-3-dodecoxypropoxy)-hydroxyphosphoryl]oxypropanoic acid

C28H56NO9P (581.3692496)

2-Amino-3-[(3-decoxy-2-dodecanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid

C28H56NO9P (581.3692496)

2-Amino-3-[(3-docosanoyloxy-2-hydroxypropoxy)-hydroxyphosphoryl]oxypropanoic acid

C28H56NO9P (581.3692496)

2-[hydroxy-[(E)-3-hydroxy-2-[[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]amino]oct-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C31H54N2O6P+ (581.3719294)

1-docosanoyl-glycero-3-phosphoserine

C28H56NO9P (581.3692496)

20-oxo-5-O-beta-mycaminosyltylactone

C31H51NO9 (581.3563636)

A macrolide antibiotic that is 20-oxotylactone having a beta-D-mycaminosyl residue attached at position 5.

DGCC 21:4;O

C31H51NO9 (581.3563636)

DGTS 21:4;O2

C31H51NO9 (581.3563636)

PC O-16:0/4:1;O2

C28H56NO9P (581.3692496)

PC O-20:1;O2

C28H56NO9P (581.3692496)

LNAPE 23:0;O

C28H56NO9P (581.3692496)

PE O-18:0/5:1;O2

C28H56NO9P (581.3692496)

PE O-23:1;O2

C28H56NO9P (581.3692496)

LPS 22:0/0:0

C28H56NO9P (581.3692496)

PS O-18:0/4:0

C28H56NO9P (581.3692496)

PS O-20:0/2:0

C28H56NO9P (581.3692496)

PS O-22:0

C28H56NO9P (581.3692496)

ST 29:2;O7;Gly

C31H51NO9 (581.3563636)

ST 23:1;O4;HexNAc

C31H51NO9 (581.3563636)

ST 27:5;O;HexNAc

C35H51NO6 (581.3716186)

Thiomyristoyl

C34H51N3O3S (581.3650936)

Thiomyristoyl is a potent and specific SIRT2 inhibitor with an IC50 of 28 nM.

2-[(1r,2s,3r,7r,8s,9s,10s,12s,14e,16s)-9-{[(2r,3s,4r,6s)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-3-ethyl-7-hydroxy-2,8,12,16-tetramethyl-5,13-dioxo-4,17-dioxabicyclo[14.1.0]heptadec-14-en-10-yl]acetaldehyde

2-[(1r,2s,3r,7r,8s,9s,10s,12s,14e,16s)-9-{[(2r,3s,4r,6s)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-3-ethyl-7-hydroxy-2,8,12,16-tetramethyl-5,13-dioxo-4,17-dioxabicyclo[14.1.0]heptadec-14-en-10-yl]acetaldehyde

C31H51NO9 (581.3563636)

2-[(4r,5s,6s,7r,9r,11e,13e,15s,16r)-6-{[(2r,3r,4s,5s,6r)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-16-ethyl-4-hydroxy-5,9,13,15-tetramethyl-2,10-dioxo-1-oxacyclohexadeca-11,13-dien-7-yl]acetaldehyde

2-[(4r,5s,6s,7r,9r,11e,13e,15s,16r)-6-{[(2r,3r,4s,5s,6r)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-16-ethyl-4-hydroxy-5,9,13,15-tetramethyl-2,10-dioxo-1-oxacyclohexadeca-11,13-dien-7-yl]acetaldehyde

C31H51NO9 (581.3563636)

2-[(7r,8s,9s,10r,12r,14e,16s)-9-{[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-3-ethyl-7-hydroxy-2,8,12,16-tetramethyl-5,13-dioxo-4,17-dioxabicyclo[14.1.0]heptadec-14-en-10-yl]acetaldehyde

2-[(7r,8s,9s,10r,12r,14e,16s)-9-{[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-3-ethyl-7-hydroxy-2,8,12,16-tetramethyl-5,13-dioxo-4,17-dioxabicyclo[14.1.0]heptadec-14-en-10-yl]acetaldehyde

C31H51NO9 (581.3563636)

2-[(1s,2r,3r,7r,8s,9r,10s,12s,14e,16s)-9-{[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-3-ethyl-7-hydroxy-2,8,12,16-tetramethyl-5,13-dioxo-4,17-dioxabicyclo[14.1.0]heptadec-14-en-10-yl]acetaldehyde

2-[(1s,2r,3r,7r,8s,9r,10s,12s,14e,16s)-9-{[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-3-ethyl-7-hydroxy-2,8,12,16-tetramethyl-5,13-dioxo-4,17-dioxabicyclo[14.1.0]heptadec-14-en-10-yl]acetaldehyde

C31H51NO9 (581.3563636)

2-[(14e)-9-{[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-3-ethyl-7-hydroxy-2,8,12,16-tetramethyl-5,13-dioxo-4,17-dioxabicyclo[14.1.0]heptadec-14-en-10-yl]acetaldehyde

C31H51NO9 (581.3563636)